M. Kopf

Type de document

Co-auteur

D. Zysset

P. Ziltener

T. Wyss

H. Wolleb

B. Weber

G. Vanoni

J. Tschopp

S. Trabanelli

A. Tardivel

F. Tacchini-Cottier

M.L. Suvà

J.C. Stehle

I. Stamenkovic

M. Siegrist

S. Schuster

C. Schürch

C. Schneider

L. Saurer

P. Romero

J.F. Romero

S. Rihs

C. Riether

W. Reith

H. Pawelski

A. Oxenius

A. Ochsenbein

J. Muri

C. Mueller

L. Michalik

D. Merkler

P. Menu

R. Loyon

M. Kreutzfeldt

P. Krebs

T. Kaufmann

C. Jandus

A. Ianaro

W. Hofstetter

P.C. Ho

U. Gurzeler

G. Guarda

O. Gross

A. Gomez-Cadena

V. Genitsch

G. Ercolano

N. Dumauthioz

C. Dostert

N. Dickgreber

G. Corradin

E.M. Carreira

P. Broz

C. Borg

Date

Source

Serveur académique Lausannois (4)

Mot-clé

Mice (3) Diseases (3) spectacle (2) effet (2) cancer (2) Cancer (2) Diseases (2) Mitochondria (2) Inflammation (2) Cytokines (2) Cancer (2) Allergy (2) Agent (Philosophy) (2) administration (1) virus (1) espèce (1) traitement (1) agent pathogène (1) métabolite (1) paludisme (1) infiltration (1) infection (1) immunité (1) gène (1) allergie (1) exposition (1) dose (1) maladie (1) désintoxication (1) investigation (1)

Documents écrit par M. Kopf (4) | parle de M. Kopf (5)

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.

G. Ercolano et al. (5 mai 2021)

Electrophilic Nrf2 activators and itaconate inhibit inflammation at low dose and promote IL-1β production and inflammatory apoptosis at high dose.

J. Muri et al.

TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance.

B. Weber et al. (2014)

Malarial hemozoin is a Nalp3 inflammasome activating danger signal.

C. Dostert et al. (2009)